Transplantation 1983.
Renal transplantation has entered a new era of optimism characterized by steady increases in our scientific appreciation of the transplant event and improving allograft survival rates. Advances in tissue typing, methods of preventing rejection including an appreciation of the blood transfusion effect and the discovery of new immunosuppressive drugs such as cyclosporin A, and methods of rejection treatment have been responsible for this new era. With renewed impetus, continued advances can only increase an optimistic approach to renal transplantation.
D000911:Antibodies, Monoclonal / Q000276:immunology; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D001803:Blood Transfusion; D003524:Cyclosporins / Q000008:administration & dosage; D006084:Graft Rejection; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D016030:Kidney Transplantation; D010951:Plasma Exchange; D011183:Postoperative Complications / Q000517:prevention & control
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D003524:Cyclosporins; D007166:Immunosuppressive Agents